exagamglogene autotemcel
experimental gene therapy for sickle cell disease and transfusion-dependent beta thalassemia
Press Enter · cited answer in seconds
0 sources
exagamglogene autotemcel
Summary
exagamglogene autotemcel is a medication[1]. It draws 696 Wikipedia views per month (medication category, ranking #46 of 213).[2]
Key Facts
- exagamglogene autotemcel's instance of is recorded as medication[3].
- exagamglogene autotemcel's instance of is recorded as gene therapy[4].
- exagamglogene autotemcel's medical condition treated is recorded as sickle-cell disease[5].
- exagamglogene autotemcel's World Health Organisation international non-proprietary name is recorded as exagamglogene autotemcel[6].
- exagamglogene autotemcel's World Health Organisation international non-proprietary name is recorded as exagamglogenum autotemcelum[7].
- exagamglogene autotemcel's World Health Organisation international non-proprietary name is recorded as exagamglogène autotemcel[8].
- exagamglogene autotemcel's World Health Organisation international non-proprietary name is recorded as exagamglogén autotemcel[9].
- exagamglogene autotemcel's World Health Organisation international non-proprietary name is recorded as эксагамглоген аутотемцел[10].
- exagamglogene autotemcel's World Health Organisation international non-proprietary name is recorded as اكساغامغلوغين اوتوتيمسيل[11].
- exagamglogene autotemcel's World Health Organisation international non-proprietary name is recorded as 艾卡基奥干赛[12].
Why It Matters
exagamglogene autotemcel draws 696 Wikipedia views per month (medication category, ranking #46 of 213).[2] It has Wikipedia articles in 6 language editions, a strong signal of global cultural recognition.[13] It is known by 11 alternative names across languages and contexts.[14]